Pretreatment Geriatric Assessments of Elderly Patients with Glioma: Development and Implications
- PMID: 32257553
- PMCID: PMC7069455
- DOI: 10.14336/AD.2019.0527
Pretreatment Geriatric Assessments of Elderly Patients with Glioma: Development and Implications
Abstract
Glioma is the most frequent primary brain tumor affecting adults, and the most lethal type is glioblastoma (GBM); currently, the available therapies only provide palliation. The treatments for low-grade glioma (LGG) include neurosurgical resection, watchful waiting, radiotherapy and chemotherapy, while the therapeutic strategies for high-grade glioma (HGG), particularly in elderly patients, have evolved to include radiotherapy, chemotherapy, and targeted monotherapy based on the characteristics of the investigated patients. Proper assessments aiming to predict and achieve the most satisfying prognosis among patients prior to surgery, radiotherapy, chemotherapy, targeted therapy or immunotherapy help summarize the pretreatment characteristics of patients, providing doctors comprehensive information to consider while determining whether the patients could benefit from ongoing treatments and deciding the proper treatment strategy for subsequent phases. This article aims to rigorously review the most recent evidence and discuss current mainstream assessments before the initiation of proper treatments for glioma, thus highlighting the potential necessity of pretreatment assessments.
Keywords: assessment; geriatric; glioma; pretreatment.
Copyright: © 2020 Wang et al.
Similar articles
-
Acute progression of untreated incidental WHO Grade II glioma to glioblastoma in an asymptomatic patient.J Neurosurg. 2016 Jan;124(1):141-5. doi: 10.3171/2014.12.JNS141851. Epub 2015 Jul 10. J Neurosurg. 2016. PMID: 26162036
-
Antiangiogenic therapy for high-grade glioma.Cochrane Database Syst Rev. 2014 Sep 22;(9):CD008218. doi: 10.1002/14651858.CD008218.pub3. Cochrane Database Syst Rev. 2014. PMID: 25242542 Updated. Review.
-
External beam radiation dose escalation for high grade glioma.Cochrane Database Syst Rev. 2016 Aug 19;(8):CD011475. doi: 10.1002/14651858.CD011475.pub2. Cochrane Database Syst Rev. 2016. PMID: 27541334 Updated. Review.
-
Survival and low-grade glioma: the emergence of genetic information.Neurosurg Focus. 2015 Jan;38(1):E6. doi: 10.3171/2014.10.FOCUS12367. Neurosurg Focus. 2015. PMID: 25552286 Free PMC article.
-
Emerging patents in the therapeutic areas of glioma and glioblastoma.Expert Opin Ther Pat. 2018 Jul;28(7):573-590. doi: 10.1080/13543776.2018.1494155. Epub 2018 Jul 9. Expert Opin Ther Pat. 2018. PMID: 29950117 Review.
Cited by
-
Development of preoperative and postoperative models to predict recurrence in postoperative glioma patients: a longitudinal cohort study.BMC Cancer. 2024 Feb 28;24(1):274. doi: 10.1186/s12885-024-11996-2. BMC Cancer. 2024. PMID: 38418976 Free PMC article.
-
Research progress of N1-methyladenosine RNA modification in cancer.Cell Commun Signal. 2024 Jan 30;22(1):79. doi: 10.1186/s12964-023-01401-z. Cell Commun Signal. 2024. PMID: 38291517 Free PMC article. Review.
-
IFN-γ Triggered IFITM2 Expression to Induce Malignant Phenotype in Elderly GBM.J Mol Neurosci. 2023 Dec;73(11-12):946-955. doi: 10.1007/s12031-023-02156-5. Epub 2023 Oct 27. J Mol Neurosci. 2023. PMID: 37889394
-
Characteristic analysis and identification of novel molecular biomarkers in elderly glioblastoma patients using the 2021 WHO Classification of Central Nervous System Tumors.Front Neurosci. 2023 Jun 9;17:1165823. doi: 10.3389/fnins.2023.1165823. eCollection 2023. Front Neurosci. 2023. PMID: 37360159 Free PMC article.
-
Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications.J Hematol Oncol. 2023 Mar 21;16(1):28. doi: 10.1186/s13045-023-01426-4. J Hematol Oncol. 2023. PMID: 36945046 Free PMC article. Review.
References
-
- Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, et al. (2016). CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. Neuro Oncol, 18:v1-v75. - PubMed
-
- Wenger NS, Solomon DH, Roth CP, MacLean CH, Saliba D, Kamberg CJ, et al. (2003). The quality of medical care provided to vulnerable community-dwelling older patients. Ann Intern Med, 139:740-747. - PubMed
-
- Kellermann SG, Hamisch CA, Ruess D, Blau T, Goldbrunner R, Treuer H, et al. (2017). Stereotactic biopsy in elderly patients: risk assessment and impact on treatment decision. J Neurooncol, 134:303-307. - PubMed
-
- Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, Parney IF (2013). Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. J Neurosurg, 118:786-798. - PubMed
Publication types
LinkOut - more resources
Full Text Sources